Liraglutide

Liraglutide
Product Description

Liraglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus and obesity management. By enhancing glucose-dependent insulin secretion and suppressing glucagon secretion, it helps improve glycemic control and promote weight reduction.

Shandong Transco Biotechnology Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2025
Specifications
  • Details
    Diabetes and weight loss
  • Model
    Api
  • Measured In
    gram

Shandong Transco Biotechnology Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2025

More Products from Shandong Transco Biotechnology Co., Ltd. (2)

  • BPC-157

    Product BPC-157

    BPC-157 is a synthetic 15-peptide derived from gastric juice protein. It has attracted much attention for its remarkable wound healing ability. It can effectively promote the repair and healing of various tissues such as tendons, gastrointestinal fistulas and skin. Its mechanisms of action are diverse, inc...
  • CJC-1295

    Product CJC-1295

    CJC-1295 is a synthetic growth hormone-releasing hormone analogue. Its core function is to continuously stimulate the pituitary gland to secrete growth hormone, thereby increasing the level of insulin-like growth factor-1 in the body, ultimately achieving the effects of promoting muscle growth, reducing bo...